Patents by Inventor Ryan M. Swanson

Ryan M. Swanson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BTNL9 proteins, nucleic acids, and antibodies and uses thereof
    Patent number: 10357561
    Abstract: The invention provides novel BTNL9 proteins, including multimers, fragments, and variants of a human BTNL9 protein. In addition, antibodies that can bind to BTNL9 proteins and nucleic acids encoding BTNL9 proteins are provided. Uses for BTNL9 proteins, and agonists or antagonists thereof, are described.
    Type: Grant
    Filed: May 5, 2015
    Date of Patent: July 23, 2019
    Inventors: Heather A. Arnett, Sabine S. Escobar, Ryan M. Swanson, Joanne L. Viney
  • BTNL9 Proteins, Nucleic Acids, and Antibodies and Uses Thereof
    Publication number: 20150344554
    Abstract: The invention provides novel BTNL9 proteins, including multimers, fragments, and variants of a human BTNL9 protein. In addition, antibodies that can bind to BTNL9 proteins and nucleic acids encoding BTNL9 proteins are provided. Uses for BTNL9 proteins, and agonists or antagonists thereof, are described.
    Type: Application
    Filed: May 5, 2015
    Publication date: December 3, 2015
    Inventors: Heather A. ARNETT, Sabine S. ESCOBAR, Ryan M. SWANSON, Joanne L. VINEY
  • BTNL9 PROTEINS, NUCLEIC ACIDS, AND ANTIBODIES AND USES THEREOF
    Publication number: 20130101590
    Abstract: The invention provides novel BTNL9 proteins, including multimers, fragments, and variants of a human BTNL9 protein. In addition, antibodies that can bind to BTNL9 proteins and nucleic acids encoding BTNL9 proteins are provided. Uses for BTNL9 proteins, and agonists or antagonists thereof, are described.
    Type: Application
    Filed: April 8, 2011
    Publication date: April 25, 2013
    Inventors: Heather A. Arnett, Sabine S. Escobar, Ryan M. Swanson, Joanne L. Viney
  • Compositions and methods for WT1 specific immunotherapy
    Publication number: 20040126362
    Abstract: Compositions and methods for the therapy of malignant diseases, such as leukemia and cancer, are disclosed. The compositions comprise one or more of a WT1 polynucleotide, a WT1 polypeptide, an antigen-presenting cell presenting a WT1 polypeptide, an antibody that specifically binds to a WT1 polypeptide; or a T cell that specifically reacts with a WT1 polypeptide. Such compositions may be used, for example, for the prevention and treatment of metastatic diseases.
    Type: Application
    Filed: August 26, 2003
    Publication date: July 1, 2004
    Applicant: Corixa Corporation
    Inventors: Alexander Gaiger, Molly D. Smithgall, Darrick Carter, Martin A. Cheever, Patricia D. McNeill, R. Alec Sutherland, Sally P. Mossman, Lawrence S. Evans, Ryan M. Swanson
  • Compositions and methods for viral delivery
    Publication number: 20030228279
    Abstract: Compositions and methods comprising a recombinant virus and an immunostimulant are provided for enhancing the immune response to a polypeptide expressed from the recombinant virus. Preferably this is done without also enhancing the neutralizing antibody response to the recombinant virus. Illustrative compositions comprise an adenovirus and an adjuvant such as, for example, monophosphoryl lipid A, an alkyl glucosaminide phosphate, a saponin, or a combination thereof. The disclosed compositions and methods are useful, for example, in the treatment of diseases such as cancer or infectious disease.
    Type: Application
    Filed: October 29, 2002
    Publication date: December 11, 2003
    Applicant: Corixa Corporation
    Inventors: Sally Mossman, Lawrence Evans, Ryan M. Swanson
  • Compositions and methods for WT1 specific immunotherapy
    Publication number: 20030198622
    Abstract: Compositions and methods for the therapy of malignant diseases, such as leukemia and cancer, are disclosed. The compositions comprise one or more of a WT1 polynucleotide, a WT1 polypeptide, an antigen-presenting cell presenting a WT1 polypeptide, an antibody that specifically binds to a WT1 polypeptide; or a T cell that specifically reacts with a WT1 polypeptide. Such compositions may be used, for example, for the prevention and treatment of metastatic diseases.
    Type: Application
    Filed: July 12, 2002
    Publication date: October 23, 2003
    Applicant: Corixa Corporation
    Inventors: Alexander Gaiger, Molly D. Smithgall, Darrick Carter, Martin A. Cheever, Patricia D. McNeill, R. Alec Sutherland, Sally P. Mossman, Lawrence S. Evans, Ryan M. Swanson
  • Compositions and methods for the diagnosis and threatment of herpes simplex virus infection
    Publication number: 20030068327
    Abstract: Compounds and methods for the diagnosis and treatment of HSV infection are provided. The compounds comprise polypeptides that contain at least one antigenic portion of an HSV polypeptide and DNA sequences encoding such polypeptides. Pharmaceutical compositions and vaccines comprising such polypeptides or DNA sequences are also provided, together with antibodies directed against such polypeptides. Diagnostic kits are also provided comprising such polypeptides and/or DNA sequences and a suitable detection reagent for the detection of HSV infection in patients and in biological samples.
    Type: Application
    Filed: April 11, 2002
    Publication date: April 10, 2003
    Applicant: Corixa Corporation
    Inventors: Nancy Ann Hosken, Patrick McGowan, Paul R. Sleath, Sally P. Mossman, Lawrence S. Evans, Ryan M. Swanson, Patricia D. McNeill